Enhance Intimacy and Sexual Desire with PT-141 (Bremelanotide)

PT-141 (Bremelanotide) is a peptide therapy that boosts sexual desire and arousal in both men and women. It works differently than traditional ED medications, acting on the central nervous system instead of blood flow. FDA-approved for treating hypoactive sexual desire disorder (HSDD) in premenopausal women, it is also commonly used off-label in men for improving libido and treating erectile dysfunction (ED).

vial
PT-141
As low as
$189
1 month supply
Start your consultation
Prescription required • No charge unless approved
What’s included
Ongoing Provider Care & Support
Syringes & Alcohol Pads Kit
Platform Access & Educational Content
Confidential online consultation
Board-certified Physicians, trusted medications
Fast, free shipping
Confidential online consultation
Board-certified Physicians, trusted medications
Fast, free shipping

What Is PT-141 Peptide and How Does It Work for Sexual Wellness?

PT-141 (Bremelanotide) is a centrally acting melanocortin receptor agonist used to enhance sexual desire and arousal in both men and women. Originally developed to treat sexual dysfunction, it is FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women and is also commonly used off-label in men with low libido or erectile dysfunction—especially when psychological or central causes are suspected. Unlike traditional ED medications, PT-141 works through the brain rather than blood flow.

Get started
side-view-of-brunette-bearded-man-and-hot-african-2025-05-20-16-55-45-utc

Get Started in 3 Simple Steps

Your personalized treatment plan is just minutes away
man-and-woman-working-remotely-using-laptop-male-2026-01-11-10-58-14-utc
1

Fill in a brief health assessment, 100% online

Complete a quick medical questionnaire from the comfort of your home
leadership-teamwork-and-portrait-doctors-and-nurs-2026-01-09-10-38-09-utc
2

Our doctors will review your answers within 24 hours

All prescriptions overseen by fully licensed and insured physicians
fast-and-friendly-service-gets-her-smiling-2026-01-09-09-24-06-utc
3

Get free home delivery if 
granted a prescription

Medications shipped discreetly to your doorstep

As see in

PT-141 Peptide Frequently Asked Questions

PT-141 (Bremelanotide) is a peptide therapy designed to enhance sexual desire and arousal. Unlike traditional ED medications that focus on blood flow, PT-141 works through the brain by activating melanocortin receptors. It is FDA-approved for treating HSDD in women and is used off-label for men with low libido or erectile dysfunction.

PT-141 typically takes 45–60 minutes to take effect and lasts 6–12 hours. For optimal results, it is typically injected 1 hour before sexual activity. With regular, consistent use, you may experience improved desire and arousal. Results will vary depending on individual needs.

Common side effects include nausea, flushing, headaches, and injection site reactions. Less common but serious side effects may include elevated blood pressure, fatigue, dizziness, and rare darkening of the gums or skin. These side effects should be monitored, and a healthcare provider can guide you in managing them.

PT-141 is administered via a subcutaneous injection, typically 1 hour before sexual activity. If you’re unfamiliar with injections, our healthcare providers can walk you through the process during your consultation. The treatment can be easily done at home for your convenience.

The effects of PT-141 typically last between 6 and 12 hours, depending on the individual. It is designed to be taken on-demand, meaning it should only be used when you feel the need for enhanced desire or sexual activity.

Yes, PT-141 is generally safe to use with other medications like TRT, HRT, or PDE5 inhibitors (like Viagra or Cialis) under the guidance of a healthcare provider. Make sure to discuss your current medications during your consultation to avoid potential interactions.

For women, the FDA guidelines recommend no more than 1 dose per 24 hours and up to 8 doses per month. For men, the frequency will be based on individual need and the provider’s recommendation.